Literature DB >> 7530115

'Prostate-related symptoms' in Canadian men 50 years of age or older: prevalence and relationships among symptoms.

R W Norman1, J C Nickel, D Fish, S N Pickett.   

Abstract

OBJECTIVES: To determine the prevalence of symptoms associated with benign prostatic hyperplasia (BPH) in Canadian men, and to establish whether the traditional separation of these symptoms into obstructive and irritative categories is valid. SUBJECTS AND METHODS: A probability sample of 508 Canadian men 50 years of age or older was surveyed by telephone. The survey questions and scoring system used were devised to allow estimation of symptom prevalence and were based on the frequency and severity of the symptoms. Using the data from respondents who had moderate to severe symptoms, a cluster analysis was utilized to analyse relationships among symptoms.
RESULTS: The most prevalent symptoms were nocturia (63%), weak stream (61%) and urinary frequency (46%). Urgency was reported by 18%, a sense of incomplete bladder emptying by 23%, intermittency by 18% and hesitancy by 13%. Using predefined cutoff scores, 23% of the respondents experienced moderate to severe symptoms associated with BPH; the prevalence of moderate to severe symptoms increased with age. The clusters were grouped on the basis of the symptoms driving them, with one cluster designated as 'moderates', two clusters designated as 'irritatives' and two designated as 'obstructives'. The moderates cluster was driven by respondents who had lower symptom scores evenly distributed across all symptoms. The irritatives and obstructives clusters were driven by respondents with higher scores for symptoms considered by convention to be irritative or obstructive in nature and, thus, were designated accordingly. Not all symptoms were discriminatory for irritative and obstructive symptom domains.
CONCLUSIONS: A large percentage of Canadian men 50 years of age or older experience symptoms commonly associated with BPH. The theoretical concept of irritative and obstructive symptom domains was supported partially by the cluster analysis. A clear typology of men with BPH symptoms could prove useful if treatments were found to be more effective for certain types of BPH symptoms. Thus these observations warrant further investigation into the differential effects of management approaches for BPH symptoms according to symptom clusters.

Entities:  

Mesh:

Year:  1994        PMID: 7530115     DOI: 10.1111/j.1464-410x.1994.tb09181.x

Source DB:  PubMed          Journal:  Br J Urol        ISSN: 0007-1331


  24 in total

1.  Prevalence of erectile dysfunction in men over 40 years of age in Turkey: Results from the Turkish Society of Andrology Male Sexual Health Study Group.

Authors:  Selahittin Çayan; Muammer Kendirci; Önder Yaman; Ramazan Aşçı; İrfan Orhan; Mustafa Faruk Usta; Oğuz Ekmekçioğlu; Ateş Kadıoğlu
Journal:  Turk J Urol       Date:  2017-06-01

2.  Disturbing nocturnal activities.

Authors:  Richard W Norman
Journal:  Can Urol Assoc J       Date:  2008-12       Impact factor: 1.862

Review 3.  Efficacy and safety of Chinese herbal medicine for benign prostatic hyperplasia: systematic review of randomized controlled trials.

Authors:  Chun Ho Ma; Wai Ling Lin; Sing Leung Lui; Xun-Yuan Cai; Vivian Taam Wong; Eric Ziea; Zhang-Jin Zhang
Journal:  Asian J Androl       Date:  2013-06-03       Impact factor: 3.285

4.  Cost analysis of fixed-dose combination of dutasteride and tamsulosin compared with concomitant dutasteride and tamsulosin monotherapy in patients with benign prostatic hyperplasia in Canada.

Authors:  Amyn Sayani; Afisi Ismaila; Anna Walker; John Posnett; Bruno Laroche; J Curtis Nickel; Zhen Su
Journal:  Can Urol Assoc J       Date:  2014 Jan-Feb       Impact factor: 1.862

Review 5.  [Diagnostics of benign prostate syndrome].

Authors:  M Seitz; A Herlemann; G Magistro; C G Stief
Journal:  Urologe A       Date:  2013-02       Impact factor: 0.639

6.  BPH: a tell-tale sign of prostate cancer? Results from the Prostate Cancer and Environment Study (PROtEuS).

Authors:  Katharina Boehm; Roger Valdivieso; Malek Meskawi; Alessandro Larcher; Maxine Sun; José Sosa; Audrey Blanc-Lapierre; Deborah Weiss; Markus Graefen; Fred Saad; Marie-Élise Parent; Pierre I Karakiewicz
Journal:  World J Urol       Date:  2015-04-01       Impact factor: 4.226

7.  Prevalence of BPH and lower urinary tract symptoms in West Africans.

Authors:  A P Chokkalingam; E D Yeboah; A Demarzo; G Netto; K Yu; R B Biritwum; Y Tettey; A Adjei; S Jadallah; Y Li; L W Chu; D Chia; S Niwa; A Partin; I M Thompson; C Roehrborn; R N Hoover; A W Hsing
Journal:  Prostate Cancer Prostatic Dis       Date:  2011-09-13       Impact factor: 5.554

8.  Energy delivery systems for treatment of benign prostatic hyperplasia: an evidence-based analysis.

Authors: 
Journal:  Ont Health Technol Assess Ser       Date:  2006-08-01

9.  Medical management of benign prostatic hyperplasia: Results from a population-based study.

Authors:  Mohamed Bishr; Katharina Boehm; Vincent Trudeau; Zhe Tian; Paolo Dell'Oglio; Jonas Schiffmann; Claudio Jeldres; Maxine Sun; Sharokh F Shariat; Markus Graefen; Fred Saad; Pierre I Karakiewicz
Journal:  Can Urol Assoc J       Date:  2016 Jan-Feb       Impact factor: 1.862

10.  Prostatic profile, premature ejaculation, erectile function and andropause in an at-risk Mexican population.

Authors:  J Jaspersen-Gastelum; J A Rodríguez; F J Espinosa de los Monteros; L Beas-Sandoval; José Guzmán-Esquivel; D D Calvo; T Gutiérrez
Journal:  Int Urol Nephrol       Date:  2008-07-15       Impact factor: 2.370

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.